Honz Pharmaceutical Co., Ltd.

SZSE:300086 Stock Report

Market Cap: CN¥1.7b

Honz Pharmaceutical Balance Sheet Health

Financial Health criteria checks 3/6

Honz Pharmaceutical has a total shareholder equity of CN¥1.3B and total debt of CN¥529.5M, which brings its debt-to-equity ratio to 39.6%. Its total assets and total liabilities are CN¥2.1B and CN¥794.7M respectively.

Key information

39.6%

Debt to equity ratio

CN¥529.47m

Debt

Interest coverage ration/a
CashCN¥114.29m
EquityCN¥1.34b
Total liabilitiesCN¥794.66m
Total assetsCN¥2.13b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300086's short term assets (CN¥569.1M) exceed its short term liabilities (CN¥391.1M).

Long Term Liabilities: 300086's short term assets (CN¥569.1M) exceed its long term liabilities (CN¥403.6M).


Debt to Equity History and Analysis

Debt Level: 300086's net debt to equity ratio (31.1%) is considered satisfactory.

Reducing Debt: 300086's debt to equity ratio has increased from 12.3% to 39.6% over the past 5 years.

Debt Coverage: 300086's debt is not well covered by operating cash flow (12.4%).

Interest Coverage: Insufficient data to determine if 300086's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.